Cramer unveils list of ‘return to normal’ actions on vaccine optimism

After Wall Street digested more positive news about the coronavirus vaccine and investors became more optimistic about reopening the trade, CNBC’s Jim Cramer unveiled a list of “back to normal” stocks on Monday.

“I think you have to buy a few of these vaccine winners if you’re weak, even though on the retail side I’m just saying buy some, period, because there’s no time to ‘wait for a dip,’ said the host of ‘Mad Money’. .

The comments come after AstraZeneca, in collaboration with the University of Oxford, said earlier today that its Covid-19 vaccine candidate was up to 90% effective in preventing the contraction of the disease which resulted in hundreds of thousands of deaths in the United States. It was the third drugmaker this month to report positive data in its vaccine study.

The news supported stocks, with the Dow Jones rallying nearly 328 points, or 1.1%, to a close of 29,591.27. The S&P 500 was raised 0.6% to 3,577.59 and the Nasdaq Composite, full of tech components, climbed 0.2% to 11,880.63.

“Either way, I’d pick a couple of those names and then wait for the next bad news that scares people off so you can buy them in weakness,” Cramer said.

“If you only had the names to stay at home, you’ve been pushed around today. But don’t worry, I think you’ll have another shot at picking up some of these lower tier vaccine winners.

Disclosure: The Cramer Charitable Trust owns shares of Mastercard, Honeywell International, Walt Disney, DuPont and Boeing.

Warning